The use of cytokine signature patterns: separating drug naïve, interferon and natalizumab-treated multiple sclerosis patients. O'Connell KE, Mok T, Sweeney B, Ryan AM, Dev KK Autoimmunity. 2014 Jun 30:1-7. PMID: 24974887. Abstract CommentRecommendBookmarkWatch